Viewing StudyNCT00251511



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00251511
Status: TERMINATED
Last Update Posted: 2012-05-11
First Post: 2005-11-08

Brief Title: A Phase II Trial of Trisenox Plus Thalomid as Treatment in Patients With Myelodysplastic Syndrome
Sponsor: Veeda Oncology
Organization: Veeda Oncology

Key Dates - Follows AllAPIJSON File Order

Start Date: 2004-08
Start Date Type: None
Primary Completion Date: 2006-01
Primary Completion Date Type: ACTUAL
Completion Date: 2007-05
Completion Date Type: ACTUAL
First Submit Date: 2005-11-08
First Submit QC Date: November 8 2005
Study First Post Date: 2005-11-10
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2012-05-09
Last Update Post Date: 2012-05-11
Last Update Post Date Type: ESTIMATED